STLN Starling Oncology, Inc.
Nasdaq · SEC CIK 1799191 · EDGAR
- Bought, last 12 months
- $2.69M 13 purchases by 1 insiders
- Sold, last 12 months
- $2.81M 7 sales by 5 insiders
- Filings on record
- 228 since 2021-11-16, latest 2026-08-24 17:11
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Chernett Jorey | 10% | $2.69M | — |
| Hively Brad | Dir | — | $2.00M |
| Kaushal Mohit | Dir | — | $335.1K |
| Podnos Yale | Chief Medical Off | — | $276.4K |
| Pacala Mark L | Dir | — | $200.0K |
| Carter Robert Ross | CFO | — | $879.32 |
| England Kristin | Chief Administrative Off | — | — |
| Langsam Jeffrey | Chief Clinical Off | — | — |
| Ling Gabriel | Dir | — | — |
| TOI M, LLC | Dir | — | — |
Transactions 242
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-25 | 2024-11-22 | STLN | Ling Gabriel | Dir | A - Grant | $0.00 | +40.0K | 109.1K | +58% | $0 | |
| 2024-11-25 | 2024-11-22 | STLN | Hively Brad | Dir | A - Grant | $0.00 | +44.0K | 720.2K | +7% | $0 | |
| 2024-11-25 | 2024-11-22 | STLN | BARASCH RICHARD A | Dir | A - Grant | $0.00 | +80.0K | 417.2K | +24% | $0 | |
| 2024-11-25 | 2024-11-22 | STLN | Pacala Mark L | Dir | A - Grant | $0.00 | +50.0K | 134.4K | +59% | $0 | |
| 2024-11-25 | 2024-11-22 | STLN | McGeorge Anne | Dir | A - Grant | $0.00 | +56.0K | 183.3K | +44% | $0 | |
| 2024-11-25 | 2024-11-22 | STLN | Johnson Karen Marie | Dir | A - Grant | $0.00 | +52.0K | 167.2K | +45% | $0 | |
| 2024-11-25 | 2024-11-22 | STLN | Kaushal Mohit | Dir | A - Grant | $0.00 | +56.0K | 177.3K | +46% | $0 | |
| M | 2024-11-21 | 2024-11-20 | STLN | Podnos Yale | Chief Medical Off | D - Sale to Iss | $0.14 | -3,002 | 74.0K | -4% | -$420.28 |
| 2024-11-21 | 2024-11-20 | STLN | Carter Robert Ross | CFO | D - Sale to Iss | $0.14 | -235 | 31.8K | -0.7% | -$32.90 | |
| M | 2024-11-21 | 2024-11-20 | STLN | Virnich Daniel | CEO | D - Sale to Iss | $0.14 | -9,727 | 717.0K | -1% | -$1,362 |
| M | 2024-11-18 | 2024-11-12 | STLN | Podnos Yale | Chief Medical Off | J - Other | $0.00 | -28.4K | 76.0K | -27% | $0 |
| M | 2024-11-18 | 2024-11-12 | STLN | Virnich Daniel | CEO | J - Other | $0.00 | -195.2K | 838.9K | -19% | $0 |
| M | 2024-11-18 | 2024-11-12 | STLN | Pacala Mark L | Dir | J - Other | $0.00 | -50.6K | 84.4K | -37% | $0 |
| MI | 2024-08-20 | 2024-08-16 | STLN | Havencrest Healthcare Partners, L.P. | 10% | J - Other | $0.00 | -16.33M | 7.88M | -67% | $0 |
| 2024-06-20 | 2024-06-17 | STLN | Hively Brad | Dir | D - Sale to Iss | $0.46 | -18.1K | 676.2K | -3% | -$8,336 | |
| 2024-05-23 | 2024-05-22 | STLN | Hively Brad | Dir | D - Sale to Iss | $0.58 | -19.5K | 694.3K | -3% | -$11.3K | |
| D | 2024-05-23 | 2024-05-21 | STLN | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +17.5K | 104.4K | +20% | $0 |
| D | 2024-05-23 | 2024-05-21 | STLN | Shah Mihir | CFO | A - Grant | $0.00 | +151.5K | 474.9K | +47% | $0 |
| D | 2024-05-23 | 2024-05-21 | STLN | Castle Jeremy | COO | A - Grant | $0.00 | +70.1K | 82.5K | +568% | $0 |
| D | 2024-05-23 | 2024-05-21 | STLN | Virnich Daniel | CEO | D - Sale to Iss | $0.6 | -11.2K | 718.4K | -2% | -$6,704 |
| D | 2024-05-23 | 2024-05-21 | STLN | Virnich Daniel | CEO | A - Grant | $0.00 | +198.5K | 916.9K | +28% | $0 |
| I | 2024-01-30 | 2024-01-29 | STLN | Havencrest Healthcare Partners, L.P. | 10% | S - Sale | $2.12 | -8,637 | 0 | -100% | -$18.3K |
| MI | 2024-01-26 | 2024-01-24+ | STLN | Havencrest Healthcare Partners, L.P. | 10% | S - Sale | $2.21 | -43.8K | 8,637 | -84% | -$96.8K |
| MI | 2024-01-23 | 2024-01-19+ | STLN | TOI HC I, LLC | 10% | S - Sale | $2.12 | -27.6K | 68.0K | -29% | -$58.6K |
| MI | 2024-01-02 | 2023-12-28 | STLN | Havencrest Healthcare Partners GP, LLC | 10% | J - Other | $0.00 | -8.56M | 8.88M | -49% | $0 |
| 2023-12-28 | 2023-12-26 | STLN | Hively Brad | Dir | A - Grant | $0.00 | +42.7K | 713.9K | +6% | $0 | |
| 2023-12-28 | 2023-12-26 | STLN | O'Meara Maeve | Dir | A - Grant | $0.00 | +50.0K | 109.1K | +85% | $0 | |
| 2023-12-28 | 2023-12-26 | STLN | Johnson Karen Marie | Dir | A - Grant | $0.00 | +52.0K | 115.2K | +82% | $0 | |
| 2023-12-28 | 2023-12-26 | STLN | McGeorge Anne | Dir | A - Grant | $0.00 | +56.0K | 127.3K | +78% | $0 | |
| 2023-12-28 | 2023-12-26 | STLN | BARASCH RICHARD A | Dir | A - Grant | $0.00 | +80.0K | 337.2K | +31% | $0 | |
| 2023-12-28 | 2023-12-26 | STLN | Pacala Mark L | Dir | A - Grant | $0.00 | +46.6K | 135.0K | +53% | $0 | |
| 2023-12-28 | 2023-12-26 | STLN | Kaushal Mohit | Dir | A - Grant | $0.00 | +53.3K | 121.3K | +79% | $0 | |
| 2023-12-28 | 2023-12-26 | STLN | Ling Gabriel | Dir | A - Grant | $0.00 | +40.0K | 69.1K | +138% | $0 | |
| M | 2023-12-18 | 2023-12-14 | STLN | Shah Mihir | CFO | P - Purchase | $1.27 | +100.0K | 327.6K | +44% | +$127.0K |
| D | 2023-12-04 | 2023-11-30 | STLN | Castle Jeremy | COO | A - Grant | $0.00 | +12.3K | 12.3K | New | $0 |
| 2023-11-22 | 2023-11-21 | STLN | Virnich Daniel | CEO | D - Sale to Iss | $2.19 | -4,322 | 729.6K | -0.6% | -$9,465 | |
| 2023-11-22 | 2023-11-21 | STLN | Hively Brad | Dir | D - Sale to Iss | $2.19 | -25.9K | 671.2K | -4% | -$56.6K | |
| 2023-11-22 | 2023-11-21 | STLN | Podnos Yale | Chief Medical Off | D - Sale to Iss | $2.19 | -1,530 | 86.8K | -2% | -$3,351 | |
| D | 2023-11-21 | 2023-11-17 | STLN | Hively Brad | Dir | S - Sale+OE | $2.24 | -25.0K | 697.1K | -3% | -$56.0K |
| D | 2023-11-21 | 2023-11-17 | STLN | Hively Brad | Dir | M - OptEx | $0.85 | +25.0K | 722.1K | +4% | +$21.2K |
| 2023-11-16 | 2023-11-14 | STLN | Virnich Daniel | CEO | D - Sale to Iss | $2.39 | -4,604 | 733.9K | -0.6% | -$11.0K | |
| M | 2023-11-16 | 2023-11-14 | STLN | Podnos Yale | Chief Medical Off | D - Sale to Iss | $2.39 | -2,098 | 88.4K | -2% | -$5,014 |
| D | 2023-11-15 | 2023-11-13 | STLN | Hively Brad | Dir | S - Sale+OE | $2.52 | -47.0K | 724.2K | -6% | -$118.4K |
| D | 2023-11-15 | 2023-11-13 | STLN | Hively Brad | Dir | M - OptEx | $0.85 | +47.0K | 771.2K | +6% | +$40.0K |
| D | 2023-11-15 | 2023-11-14 | STLN | Hively Brad | Dir | D - Sale to Iss | $2.39 | -27.1K | 697.1K | -4% | -$64.8K |
| M | 2023-05-24 | 2023-05-23 | STLN | Shah Mihir | CFO | D - Sale to Iss | $0.43 | -3,442 | 224.3K | -2% | -$1,480 |
| 2023-03-21 | 2023-03-17 | STLN | Pacala Mark L | Dir | A - Grant | $0.00 | +6,562 | 88.4K | +8% | $0 | |
| D | 2023-03-21 | 2023-03-17 | STLN | Hively Brad | CEO, Dir | A - Grant | $0.00 | +168.5K | 724.2K | +30% | $0 |
| 2023-03-21 | 2023-03-17 | STLN | McGeorge Anne | Dir | A - Grant | $0.00 | +26.2K | 71.3K | +58% | $0 | |
| D | 2023-03-21 | 2023-03-17 | STLN | Shah Mihir | CFO | A - Grant | $0.00 | +176.2K | 226.9K | +347% | $0 |
| 2023-03-21 | 2023-03-17 | STLN | Johnson Karen Marie | Dir | A - Grant | $0.00 | +19.7K | 63.2K | +45% | $0 | |
| 2023-03-21 | 2023-03-17 | STLN | SARIN RAVI YANG | Dir | A - Grant | $0.00 | +29.5K | 75.4K | +64% | $0 | |
| D | 2023-03-21 | 2023-03-17 | STLN | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +33.2K | 90.5K | +58% | $0 |
| D | 2023-03-21 | 2023-03-17 | STLN | Virnich Daniel | Pres | A - Grant | $0.00 | +114.9K | 738.5K | +18% | $0 |
| 2023-03-21 | 2023-03-17 | STLN | O'Meara Maeve | Dir | A - Grant | $0.00 | +16.4K | 59.1K | +38% | $0 | |
| D | 2023-03-21 | 2023-03-17 | STLN | Miller Matthew P | COO | A - Grant | $0.00 | +67.7K | 243.0K | +39% | $0 |
| 2023-03-21 | 2023-03-17 | STLN | Kaushal Mohit | Dir | A - Grant | $0.00 | +19.7K | 42.4K | +87% | $0 | |
| M | 2023-03-21 | 2023-03-17 | STLN | BARASCH RICHARD A | Dir | P - Purchase | $0.55 | +50.0K | 217.2K | +30% | +$27.5K |
| A | 2022-12-30 | 2022-11-17 | STLN | BARASCH RICHARD A | Dir | A - Grant | $0.00 | +65.2K | 207.2K | +46% | $0 |
| 2022-12-20 | 2022-12-16 | STLN | Miller Matthew P | COO | P - Purchase | $0.95 | +73.7K | 175.3K | +72% | +$70.0K | |
| DM | 2022-12-08 | 2022-12-07 | STLN | Virnich Daniel | Pres | M - OptEx | $0.86 | +350.0K | 623.6K | +128% | +$301.0K |
| A | 2022-11-22 | 2022-11-15 | STLN | Podnos Yale | Chief Medical Off | S - Sale | $2.03 | -199 | 43.1K | -0.5% | -$403.97 |
| A | 2022-11-22 | 2022-11-15 | STLN | Virnich Daniel | Pres | S - Sale | $2.03 | -3,767 | 233.5K | -2% | -$7,647 |
| A | 2022-11-22 | 2022-11-15 | STLN | Hively Brad | CEO | S - Sale | $2.03 | -9,718 | 452.2K | -2% | -$19.7K |
| A | 2022-11-22 | 2022-11-15 | STLN | Simoneit Diona | CAO | S - Sale | $2.03 | -190 | 29.3K | -0.6% | -$385.70 |
| A | 2022-11-22 | 2022-11-15 | STLN | Miller Matthew P | COO | S - Sale | $2.03 | -577 | 78.0K | -0.7% | -$1,171 |
| 2022-11-21 | 2022-11-17 | STLN | McGeorge Anne | Dir | A - Grant | $0.00 | +22.7K | 45.1K | +101% | $0 | |
| D | 2022-11-21 | 2022-11-17 | STLN | Virnich Daniel | Pres | A - Grant | $0.00 | +40.1K | 273.6K | +17% | $0 |
| D | 2022-11-21 | 2022-11-17 | STLN | Simoneit Diona | CAO | A - Grant | $0.00 | +10.4K | 39.7K | +35% | $0 |
| D | 2022-11-21 | 2022-11-17 | STLN | Miller Matthew P | COO | A - Grant | $0.00 | +23.6K | 101.6K | +30% | $0 |
| M | 2022-11-21 | 2022-11-17 | STLN | Pacala Mark L | Dir | A - Grant | $0.00 | +31.2K | 52.8K | +145% | $0 |
| 2022-11-21 | 2022-11-17 | STLN | Johnson Karen Marie | Dir | A - Grant | $0.00 | +22.7K | 43.5K | +109% | $0 | |
| 2022-11-21 | 2022-11-17 | STLN | SARIN RAVI YANG | Dir | A - Grant | $0.00 | +22.7K | 45.9K | +98% | $0 | |
| 2022-11-21 | 2022-11-17 | STLN | Ling Gabriel | Dir | A - Grant | $0.00 | +29.1K | 29.1K | New | $0 | |
| D | 2022-11-21 | 2022-11-17 | STLN | Shah Mihir | CFO | A - Grant | $0.00 | +18.6K | 50.7K | +58% | $0 |
| D | 2022-11-21 | 2022-11-17 | STLN | Hively Brad | CEO | A - Grant | $0.00 | +103.5K | 555.7K | +23% | $0 |
| 2022-11-21 | 2022-11-17 | STLN | Kaushal Mohit | Dir | A - Grant | $0.00 | +22.7K | 48.2K | +89% | $0 | |
| D | 2022-11-21 | 2022-11-17 | STLN | Podnos Yale | Chief Medical Off | A - Grant | $0.00 | +14.2K | 57.2K | +33% | $0 |
| 2022-11-21 | 2022-11-17 | STLN | BARASCH RICHARD A | Dir | A - Grant | $0.00 | +22.7K | 164.7K | +16% | $0 | |
| 2022-11-21 | 2022-11-17 | STLN | O'Meara Maeve | Dir | A - Grant | $0.00 | +22.7K | 42.7K | +114% | $0 | |
| 2022-11-17 | 2022-11-15 | STLN | Miller Matthew P | COO | D - Sale to Iss | $2.03 | -577 | 78.0K | -0.7% | -$1,171 | |
| 2022-11-17 | 2022-11-15 | STLN | Simoneit Diona | CAO | D - Sale to Iss | $2.03 | -190 | 29.3K | -0.6% | -$385.70 | |
| 2022-11-17 | 2022-11-15 | STLN | Podnos Yale | Chief Medical Off | D - Sale to Iss | $2.03 | -199 | 43.1K | -0.5% | -$403.97 | |
| 2022-11-17 | 2022-11-15 | STLN | Virnich Daniel | Pres | D - Sale to Iss | $2.03 | -3,767 | 233.5K | -2% | -$7,647 | |
| 2022-11-17 | 2022-11-15 | STLN | Hively Brad | CEO | D - Sale to Iss | $2.03 | -9,718 | 452.2K | -2% | -$19.7K | |
| I | 2022-11-15 | 2022-11-11 | STLN | Havencrest Healthcare Partners, L.P. | 10% | S - Sale | $2.33 | -365.3K | 13.36M | -3% | -$851.2K |
| 2022-11-15 | 2022-11-14 | STLN | Kaushal Mohit | Dir | S - Sale | $2.13 | -16.0K | 25.5K | -39% | -$34.1K | |
| MI | 2022-11-10 | 2022-11-08+ | STLN | Havencrest Healthcare Partners, L.P. | 10% | S - Sale | $3.07 | -168.3K | 13.87M | -1% | -$517.3K |
| MI | 2022-11-07 | 2022-11-03+ | STLN | Havencrest Healthcare Partners, L.P. | 10% | S - Sale | $3.45 | -114.9K | 13.97M | -0.8% | -$395.9K |
| MI | 2022-11-02 | 2022-10-31+ | STLN | Havencrest Healthcare Partners, L.P. | 10% | S - Sale | $4.26 | -150.6K | 14.12M | -1% | -$640.9K |
| MI | 2022-10-28 | 2022-10-26+ | STLN | Havencrest Healthcare Partners, L.P. | 10% | S - Sale | $5.02 | -139.6K | 14.16M | -1.0% | -$701.2K |
| 2022-10-25 | 2022-10-24 | STLN | Kaushal Mohit | Dir | S - Sale | $4.96 | -4,798 | 41.5K | -10% | -$23.8K | |
| MI | 2022-10-25 | 2022-10-21+ | STLN | Havencrest Healthcare Partners GP, LLC | 10% | S - Sale | $5.02 | -79.8K | 14.30M | -0.6% | -$400.7K |
| MI | 2022-10-20 | 2022-10-18+ | STLN | Havencrest Healthcare Partners, L.P. | 10% | S - Sale | $4.71 | -41.7K | 14.41M | -0.3% | -$196.3K |
| MI | 2022-10-17 | 2022-10-13+ | STLN | Havencrest Healthcare Partners GP, LLC | 10% | S - Sale | $4.63 | -43.2K | 14.44M | -0.3% | -$200.1K |
| MI | 2022-10-12 | 2022-10-10+ | STLN | TOI HC I, LLC | 10% | S - Sale | $4.55 | -60.8K | 14.47M | -0.4% | -$277.0K |
| DI | 2022-10-07 | 2022-10-05 | STLN | BARASCH RICHARD A | Dir | J - Other | $0.00 | +8 | 8 | New | $0 |
| D | 2022-10-07 | 2022-10-05 | STLN | BARASCH RICHARD A | Dir | J - Other | $0.00 | +1 | 142.0K | +0.0% | $0 |
| MI | 2022-10-07 | 2022-10-05+ | STLN | TOI HC I, LLC | 10% | S - Sale | $4.57 | -62.2K | 14.58M | -0.4% | -$284.2K |
| MI | 2022-10-04 | 2022-09-30+ | STLN | Havencrest Healthcare Partners, L.P. | 10% | S - Sale | $4.77 | -51.2K | 14.63M | -0.3% | -$244.3K |
Purchase Sale Sale after option exercise All abbreviations